Moreover, AHNAK overexpression predicts poor clinical outcome in larynx carcinoma patients (66) and reduced actin cytoskeleton dynamics and suppression of cell migration was assessed recently by AHNAK knock-down in six metastatic tumor cell lines (67). This evidence concerns the gene AHNAK and laryngeal carcinoma.